Home / Business and Economy / Health Costs Skyrocket: Employers Brace for Double-Digit Hikes
Health Costs Skyrocket: Employers Brace for Double-Digit Hikes
2 Sep
Summary
- Employer healthcare costs projected to rise 11% next year.
- GLP-1 drugs and AI use cited as new cost contributors.
- Companies explore direct contracts and network steering.

Employers are bracing for a significant increase in healthcare costs, with projections indicating an average rise of 11% for the upcoming year, the steepest jump in decades. Even after implementing benefit reductions, costs are still expected to climb approximately 8%. This trend is placing considerable strain on businesses and employees alike.
Several factors are driving these escalating costs. Among them are the rising prices of hospital care and prescription drugs, including expensive cancer medications and GLP-1 drugs used for conditions like diabetes. Additionally, the use of artificial intelligence by healthcare providers to improve billing documentation and the exploitation of consumer protection laws by out-of-network doctors are contributing factors.
Many companies are actively seeking new strategies to control expenses. This includes exploring direct contracting with hospitals and doctors for specific services, demanding greater transparency from insurers regarding spending, and re-evaluating arrangements with pharmacy benefit managers. Some are even considering steering employees towards preferred providers to manage costs, though this may raise concerns about employee choice.
The impact of these rising costs is substantial, affecting approximately 160 million people under 65 who rely on employer-sponsored health insurance. Workers are facing higher premiums, deductibles, and co-pays, forcing them to shoulder a larger portion of their medical expenses. This situation is described as unsustainable by benefits administrators, pushing organizations to fundamentally rethink their healthcare provision models.